Edition:
United States

Acorda Therapeutics Inc (ACOR.OQ)

ACOR.OQ on NASDAQ Stock Exchange Global Select Market

26.40USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$26.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
198,797
52-wk High
$33.00
52-wk Low
$13.65

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.60 December 23 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 4 3 3 3
(3) HOLD 5 5 6 5
(4) UNDERPERFORM 1 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.70 2.90 2.91 2.90

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 10 132.76 148.60 116.30 --
Quarter Ending Jun-18 10 149.22 163.20 120.30 --
Year Ending Dec-18 11 403.45 623.04 343.30 642.09
Year Ending Dec-19 10 210.18 718.10 85.30 689.72
Earnings (per share)
Quarter Ending Mar-18 6 0.60 1.02 0.23 --
Quarter Ending Jun-18 6 0.95 1.34 0.72 --
Year Ending Dec-18 7 0.76 2.97 -0.15 1.70
Year Ending Dec-19 5 -2.62 -1.45 -4.35 1.79

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 171.72 188.40 16.68 9.71
Quarter Ending Sep-17 150.63 141.07 9.57 6.35
Quarter Ending Jun-17 140.07 139.44 0.63 0.45
Quarter Ending Mar-17 127.33 119.39 7.95 6.24
Quarter Ending Dec-16 138.70 140.63 1.93 1.39
Earnings (per share)
Quarter Ending Dec-17 1.05 0.61 0.44 41.90
Quarter Ending Sep-17 0.65 0.43 0.22 34.14
Quarter Ending Jun-17 0.48 0.29 0.19 39.04
Quarter Ending Mar-17 0.09 -0.08 0.17 187.53
Quarter Ending Dec-16 0.12 0.05 0.07 59.61

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 132.76 131.60 132.14 131.83 --
Quarter Ending Jun-18 149.22 142.30 142.85 138.49 --
Year Ending Dec-18 403.45 395.24 394.32 403.71 642.09
Year Ending Dec-19 210.18 219.09 219.88 226.10 689.72
Earnings (per share)
Quarter Ending Mar-18 0.60 0.67 0.68 0.60 --
Quarter Ending Jun-18 0.95 1.01 1.09 0.82 --
Year Ending Dec-18 0.76 0.97 0.93 0.62 1.70
Year Ending Dec-19 -2.62 -2.47 -2.33 -2.31 1.79

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 3 2 3 2
Quarter Ending Jun-18 3 2 3 2
Year Ending Dec-18 4 3 4 3
Year Ending Dec-19 3 3 3 3
Earnings
Quarter Ending Mar-18 2 1 1 1
Quarter Ending Jun-18 1 2 0 2
Year Ending Dec-18 0 3 1 2
Year Ending Dec-19 0 2 0 2